Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting patients earlier, particularly patients with smear-negative TB disease. This document provides a pragmatic summary of the evidence and recommendation...
The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...
Direct sputum smear microscopy is the most widely used means for the diagnosis of pulmonary tuberculosis (TB) and is available in most primary health-care laboratories at health-centre level. Smear microscopy may, however, be costly and inconvenient for patients, who have to make multiple visits to healt...
This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition.
First, the recommendation to discontinue the regimen based on just 2 months of rifampicin (2HRZE...
These guidelines aim to provide a strategic approach to reducing morbidity and mortality related to TB and HIV among at-risk drug users and their communities in a way that promotes holistic and person-centered services. They are intended for professionals dealing with the drug users who have the most pro...
In June 2005, WHO’s Strategic, Technical and Advisory Group on TB approved the
new Stop TB Strategy, which was endorsed by the Stop TB Partnership Coordinating
Board in November 2005. The new Strategy was designed to deal with challenges and obstacles that slow the progress in achieving tuberculosis co...
Since the publication of the Tuberculosis handbook by the World Health Organization in 1998, important changes have taken place in the global context in which control of tuberculosis (TB) is carried out. Firstly, the DOTS strategy has been adopted by virtually all countries during the past decade, althou...
This is a dynamic and challenging time for those working in public health, in global health cooperation, and in tuberculosis control specifically. As a result of commitments to health at the highest political levels, there are unprecedented opportunities for expanding response to disease epidemics and si...
Until very recently, the approaches to TB care and control have been focused in most
settings on the essential public health and medical interventions with very limited
scope to contribution by communities. And yet, the issue of community involvement
in public health approaches and in the delivery of hea...
